In vitro models show it enhances superoxide dismutase activity for antioxidant effects and stimulates metalloproteinases for matrix turnover
Journal of Clinical Pharmacology, 63(12), 1121-1130
Most of these effects appear to outperform placebo
Bes F, Hofman W, Schuur J, Van Boxtel C
The dosage chart presented here provides a framework, but the clinical nuances, specifically the titration pace, the dose ceiling, the choice of synergistic agents, and the biomarker monitoring schedule, should be individualized by a physician familiar with both the patient's metabolic history and the evolving evidence base for mitochondrial peptide therapy
The peptide degrades faster at room temperature due to hydrolysis of peptide bonds, particularly at the Trp-Ala segment